Exhibit 1

JOINT FILING AGREEMENT
 
In accordance with Rule 13d-1(k), as promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock, par value $0.00001 per share of Veradermics, Incorporated and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 11, 2026.
 
Dated: February 11, 2026
 
 
AVERILL MASTER FUND, LTD.
 
 
 
 
 
 
 
 
 
 
 
By:
/s/ Andrew Nathanson                                                  
 
 
Name:
 Andrew Nathanson
 
 
Title:
Authorized Signatory
 
 
 
 
 
AVERILL MADISON MASTER FUND, LTD.
 
 
 
 
 
 
 
By:
/s/ Andrew Nathanson                                                  
 
 
Name:
Andrew Nathanson
 
 
Title:
Authorized Signatory
 
 
 
 
 
 
SUVRETTA CAPITAL MANAGEMENT, LLC
 
 
 
 
 
 
By:
/s/ Andrew Nathanson                                                  
 
 
Name:
Andrew Nathanson
 
 
Title:
General Counsel and Chief Compliance Officer
 
 
 
 
 
 
/s/ Aaron Cowen                                                              
 
Aaron Cowen